Dennis M. Brown - Feb 13, 2019 Form 4 Insider Report for Cell Source, Inc. (CLCS)

Role
Director
Signature
/s/ Dennis M. Brown
Stock symbol
CLCS
Transactions as of
Feb 13, 2019
Transactions value $
$58,966
Form type
4
Date filed
6/10/2021, 01:40 PM
Next filing
Jul 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLCS Common Stock Other $4.45K +5.93K +5.93% $0.75 106K Dec 31, 2019 Direct F1
transaction CLCS Common Stock Other $2.24K +2.99K +2.82% $0.75 109K Jun 30, 2020 Direct F1
transaction CLCS Common Stock Other $2.27K +3.03K +2.78% $0.75 112K Dec 29, 2020 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLCS Series A Convertible Preferred Stock Award $50K +6.67K $7.50* 6.67K Feb 13, 2019 Common Stock 66.7K $0.75 Direct F2
transaction CLCS Director Stock Option (Right to Buy) Award $0 +450K $0.00 450K Aug 19, 2020 Common Stock 450K $0.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued as payment-in-kind dividend on Series A Convertible Preferred Stock.
F2 The Series A Convertible Preferred Stock has no expiration date.